From: Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study
N | % | ||
---|---|---|---|
Age (n = 54) | ≤ 35 years | 24 | 44,4 |
>35 years | 30 | 55,6 | |
Histological type (n = 54) | NS | 26 | 48,1 |
MC | 24 | 44,4 | |
LR | 3 | 5,6 | |
NLP | 1 | 1,9 | |
Therapy (n = 22) | ABVD | 20 | 91,0 |
ABVD+CMOPP | 1 | 4,5 | |
ABVD+ CBVP-K | 1 | 4,5 | |
Stage (n = 23) | 1 | 3 | 13,0 |
2 | 6 | 26,1 | |
3 | 10 | 43,5 | |
4 | 4 | 17,4 | |
Bulky (n = 23) | Yes | 2 | 8,7 |
No | 21 | 91,3 | |
RT (n = 23) | Yes | 9 | 39,1 |
No | 14 | 60,9 |